On the one hand, the loss of NICD1 immunoreactivity in CLL cells in soft tissues adjacent to lymph nodes suggests that the levels of NOTCH1 activation differ in CLL cells in different microenvironments within an individual patient. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.